Kimberly Cantillon, MPAS, PA-C, is a physician associate with extensive experience in diabetes diagnosis and treatment. She obtained her undergraduate degree from the University of Michigan and her master’s degree from Wayne State University. She spent the first 13 years of her clinical practice in primary care, focusing specifically on caring for patients with type 2 diabetes, and then two years in endocrinology. For the past three years, Ms. Cantillon has worked in medical affairs, focusing on education around chronic kidney disease, cardiovascular disease, and type 2 diabetes. She leads journal clubs, is involved in clinical research, and provides educations to clinicians and students.
Kimberly's Shared Resources
Albuminuria in Heart Failure: A Strong Predictor of Risk and Outcomes
Albuminuria is prevalent in patients with heart failure (HF) and independently associated with increased risk of adverse outcomes. The causes...
EMPA-KIDNEY Trial Shows Empagliflozin Reduces CKD Progression and Cardio Risks
The EMPA-KIDNEY trial evaluated empagliflozin's effectiveness in patients with chronic kidney disease (CKD) at various stages of progression. Participants with...
Advancing Therapies: Non-Steroidal MR Antagonists in the Spotlight for Treating Chronic Conditions
MR overactivation, implicated in various pathologies including chronic kidney disease (CKD) and type 2 diabetes mellitus, underscores the importance of...
Finerenone Reduces Heart, Kidney Risks in Diabetes CKD Study
The FIDELITY analysis consolidated data from the FIDELIO-DKD and FIGARO-DKD studies, targeting patients with type 2 diabetes across different stages...
